Organisation of our company counts with a group of medical doctors specialized in cannabinoid treatments, laboratory technicians and scientific consultants to ensure the quality of production and commercial agents to help you get the most relevant product for your requirements. Our mission is to provide comprehensive support to our clients regarding the administration of CBD products for the management of some of the hardest diseases known to mankind and their adverse effects. Cannabidiol or CBD, is a non-psychotropic cannabinoid extracted from industrial hemp. Pre-clinical and Clinical studies emphasize its capabilities to counter the effects produced by Tetrahydrocannabinol - THC (psychotropic molecule from cannabis), promote great variety of benefits in the management of multiple diseases and chronic conditions such as cancer, epilepsy, rheumatoid arthritis (RA), muscular pain, cognitive memory; as well as to aid in lessening adverse effects of conventional therapies. Among the profiles of who could benefit by the use of CBD you can find: Individuals with a terminal or chronic disease o those who seek to lessen the adverse effects of conventional treatments and individuals who seek to prevent said conditions.
Looking for a particular Sativida® employee's phone or email?
The Sativida® annual revenue was $4 million in 2026.
2 people are employed at Sativida®.
Sativida® is based in Houston, Texas.
The NAICS codes for Sativida® are [32541, 3254, 325, 32].
The SIC codes for Sativida® are [283, 28].